Amrize stock gains 2.19% as roofing pressure stays in focus
Published on 11/09/2026 at 17:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMixed signals for Amrize
- Commercial roofing demand and pricing support revenue, while residential roofing and input costs delay broader margin recovery.
- Management expects Building Envelope to become price-cost positive in 2027 and Building Materials to reach that point in the fourth quarter.
- The updated outlook makes pricing, surcharges and efficiency savings the next key tests for investors.
Amrize stock traded at 38.22 euros on Lang & Schwarz at 17:06 CET on Monday, November 9, 2026, 2.19 percent above the 37.40-euro quote cited in the earlier Amrize report at 10:37 CET the same day. The move is a separate comparison with that report and is not an Xetra close comparison.
Growth meets uneven margins
Amrize reported third-quarter results for the period ended September 30 on October 28. Revenue rose 2.2 percent year over year to 3.771 billion US dollars, while net income increased 3.3 percent to 558 million US dollars. Diluted earnings per share rose 4.1 percent to 1.02 US dollars, while adjusted diluted earnings per share was unchanged at 1.05 US dollars.
Adjusted EBITDA edged up 0.2 percent to 1.076 billion US dollars, but the adjusted EBITDA margin narrowed to 28.5 percent from 29.1 percent. Price increases, surcharges and acquisitions supported the result, while lower volumes and higher freight, diesel and raw-material costs limited the operating benefit. The company's investor-relations page provides the third-quarter release and related materials.
Roofing remains the pressure point
Building Materials revenue rose 1.8 percent to 2.842 billion US dollars, and segment adjusted EBITDA increased 2.7 percent to 938 million US dollars. Cement pricing rose 1.8 percent on a constant-currency basis, while aggregates pricing increased 6.9 percent.
Building Envelope revenue grew 3.6 percent to 929 million US dollars, supported by commercial roofing, data-center and industrial projects and higher pricing. Segment adjusted EBITDA fell 14.6 percent to 182 million US dollars as freight and raw-material costs outweighed pricing and surcharge benefits. A lack of major storms and sluggish existing-home sales also pressured shingle volumes.
Management expects commercial roofing volumes to remain resilient, while residential roofing is likely to stay softer. Building Envelope price-cost performance should improve sequentially in the fourth quarter, but the company now expects the segment to become price-cost positive in 2027 rather than 2026.
Guidance sets the next test
Amrize's updated 2026 outlook calls for revenue of 12.2 billion to 12.4 billion US dollars and adjusted EBITDA of 2.95 billion to 3.05 billion US dollars. Building Materials is expected to become price-cost positive in the fourth quarter.
The ASPIRE efficiency program delivered 73 million US dollars of savings in the first nine months and remains on track for 80 million US dollars in 2026. Amrize also completed its 1 billion US dollar share-repurchase program on October 28. For investors, the key question is whether pricing, surcharges and savings can offset softer residential roofing demand and cost inflation.
Amrize company facts
- Company: Amrize Ltd
- ISIN: CH1430134226
- Ticker: AMRZ
- Listings: NYSE and SIX
- Lang & Schwarz quote: 38.22 euros at 17:06 CET on November 9, 2026
- Change since the earlier report: 2.19 percent from 37.40 euros at 10:37 CET on November 9, 2026
The Amrize stock topic page collects further company coverage.
The Swiss SMI provides the relevant regional market context for Amrize investors.
More company-specific coverage is available in More news and analyses on Amrize stock.
